Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Chemistry Search & Selection

Chemistry Search & Selection was founded in 2006 with the goal of becoming the most trusted and knowledgeable team of recruiters working in healthcare communications. With each successful placement we hope our clients and candidates would say we have achieved that goal. Our consultants all have extensive experience of the healthcare communications industry, through either a strong background working in healthcare communications or a long-term career recruiting in this sector.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

Digital communications, Medical education, Recruitment and career development

Company Details

Chemistry Search & Selection
1st Floor, Abbey House, 74-76 St John St, London, EC1M 4DZ, United Kingdom
+44 (0)20 8866 2418
Contact Chemistry Search & Selection
Website

 Latest Content from PMHub 

Article: Getting their lives back: Improving options for people with Lupus

White Papers and Resources | July 14, 2022 | Inizio

Head of Therapy Watch, Helen Parfitt and Head of Living With, Mariel Metcalfe, investigate Lupus from the perspective of both healthcare professionals and patients using data from our syndicated products.

HOW DID COVID-19 AFFECT PRESCRIBING BEHAVIOURS? FIVE KEY FINDINGS FROM A NEW STATE OF THE NATION REVIEW

Press Releases | July 14, 2022 | Wilmington Healthcare

Published earlier this month, Wilmington Healthcare’s new State of the Nation report draws on a raft of data from across primary and secondary care to show what actually happened to...

Accelerating patient recruitment post-COVID-19

White Papers and Resources | July 12, 2022 | Innovative Trials

COVID-19 has hugely affected clinical trials and patient recruitment, with the entire industry on hold for some time causing backlogs and delays most of the studies.

Genesis Research Acquires Market Access Transformation

Press Releases | July 11, 2022 | Genesis Research Group

Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services, has entered into a definitive agreement to acquire Market Access Transformation (“MAT”),...

Bedrock’s Accelerated Virtual Consensus Programme for Merck wins at Communiqué Awards

Press Releases | July 11, 2022 | Bedrock Healthcare Communications

The award recognises outstanding achievement in flexing thinking and processes to ensure success.

ISPOR 2022: a retrospective

Videos and Podcasts | July 11, 2022 | Genesis Research Group

Genesis Research – an introduction

Videos and Podcasts | July 11, 2022 | Genesis Research Group

Ensuring fit-for-purpose real-world data to generate real-world evidence with Susan Oliveria

Videos and Podcasts | July 11, 2022 | Genesis Research Group

Genesis Research at the World EPA Congress 2022

Videos and Podcasts | July 11, 2022 | Genesis Research Group

Traversing the Medtech Regulatory Landscape in the Interest of Patients

Videos and Podcasts | July 7, 2022 | Impetus Digital

Dr. Bassil Akra, CEO of AKRA TEAM GmbH, takes a deep dive into the new approval process for medical devices in the EU and shares how his company is supporting...